Skov J, Dejgaard A, Frkir J, et al
Tirzepatide goes up to 15mg, and many people experience renewed weight loss at higher doses
IUBMB Life 57 , 283295 (2005)
GLP-1 Match Score Average to high prices compared to other providers Services all 50 states Surprisingly fast customer service for large company Reviews are mixed Holistic support, but not included in GLP-1 med price 84 Good nationwide support and fast service
Finally, ongoing and future implementation of modeling, risk assessment, and other AI tools to assist method development, data processing, and technological development, workflows will strengthen decision-making capabilities
Key findings include: Mean weight loss of 24.2% (approximately 58 pounds or 26.2 kg) with 12 mg weekly dose after 48 weeks Dose-dependent efficacy across 1 mg, 4 mg, 8 mg, and 12 mg dose groups At 48 weeks, 100% of participants receiving 8 mg or 12 mg achieved at least 5% weight loss 93% of participants on 12 mg achieved 15% or more weight loss , far exceeding current therapeutic benchmarks Greater weight reduction observed in participants with BMI greater than or equal to 35 compared to those with BMI below 35 The magnitude of weight loss approaches that typically observed only with bariatric-metabolic surgery, representing a potential paradigm shift in pharmacological obesity treatment[11]